Gene Therapy Effective in Dogs With Cone-Rod Dystrophy

As reported October 29, 2013 in the journal Molecular Therapy, a French research team led by Fabienne Rolling, Ph.D., of INSERM has used gene therapy to restore vision in dogs affected by cone-rod dystrophy. CRD is caused by mutations in the gene RPGRIP1. In this study, retinal cone cell (central vision) function was significantly rescued [Read More]

B Vitamins: Brain and Eye Health

by Ellen Troyer, MT MA, with Spencer Thornton, MD Evidence continues to mount that links B vitamins deficiency, specifically B6, B12 and folate, to increased risk of developing Macular Degeneration and Alzheimer’s, as well as faster progression of the two disease processes. PLoS One, the open-access journal for the communication of all peer-reviewed scientific and [Read More]

Predictors of Advanced AMD Defined

According to members of the Three Continent AMD Consortium (3CC), prediction models for age-related macular degeneration (AMD) based on case-control studies have a tendency to overestimate risks. To provide more well-defined data, 3CC developed a prediction model for late AMD based on data from population-based studies. Using data from the Rotterdam Study, the Beaver Dam [Read More]